Integrating bench with bedside: The role of vaccine therapy in the treatment of solid tumors

被引：3

作者：

Kaufman, HL ^{[1
]}

机构：

[1] Columbia Univ, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 04期

关键词：

D O I：

10.1200/JCO.2005.09.908

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：659 / 661

页数：3

相关论文

共 13 条

[1] External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing [J].

Chakraborty, M ;

Abrams, SI ;

Coleman, CN ;

Camphausen, K ;

Schlom, J ;

Hodge, JW .

CANCER RESEARCH, 2004, 64 (12) :4328-4337

[2] Dose-related effects of smallpox vaccine [J].

Frey, SE ;

Newman, FK ;

Cruz, J ;

Shelton, WB ;

Tennant, JM ;

Polach, T ;

Rothman, AL ;

Kennedy, JS ;

Wolff, M ;

Belshe, RB ;

Ennis, FA .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (17) :1275-1280

[3] Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule [J].

Hörig, H ;

Lee, DS ;

Conkright, W ;

Divito, J ;

Hasson, H ;

LaMare, M ;

Rivera, A ;

Park, D ;

Tine, J ;

Guito, K ;

Tsang, KWY ;

Schlom, J ;

Kaufman, HL .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2000, 49 (09) :504-514

[4] A RECOMBINANT VACCINIA VIRUS EXPRESSING HUMAN CARCINOEMBRYONIC ANTIGEN (CEA) [J].

KAUFMAN, H ;

SCHLOM, J ;

KANTOR, J .

INTERNATIONAL JOURNAL OF CANCER, 1991, 48 (06) :900-907

[5] Phase I study of sequential vaccinations with fowlpox-CEA(6D)-TRICOM alone and sequentially with vaccinia-CEA(6D)-TRICOM, with and without granulocyte-macrophage colony-stimulating factor, in patients with carcinoembryonic antigen-expressing carcinomas [J].

Marshall, JL ;

Gulley, JL ;

Arlen, PM ;

Beetham, PK ;

Tsang, KY ;

Slack, R ;

Hodge, JW ;

Doren, S ;

Grosenbach, DW ;

Hwang, J ;

Fox, E ;

Odogwu, L ;

Park, S ;

Panicali, D ;

Schlom, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :720-731

[6] Phase I study in cancer patients of a replication-defective avipox recombinant vaccine that expresses human carcinoembryonic antigen [J].

Marshall, JL ;

Hawkins, MJ ;

Tsang, KY ;

Richmond, E ;

Pedicano, JE ;

Zhu, MZ ;

Schlom, J .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :332-337

[7] Phase I study in advanced cancer patients of a diversified prime-and-boost vaccination protocol using recombinant vaccinia virus and recombinant nonreplicating avipox virus to elicit anti-carcinoembryonic antigen immune responses [J].

Marshall, JL ;

Hoyer, RJ ;

Toomey, MA ;

Faraguna, K ;

Chang, P ;

Richmond, E ;

Pedicano, JE ;

Gehan, E ;

Peck, RA ;

Arlen, P ;

Tsang, KY ;

Schlom, J .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (23) :3964-3973

[8] Results of a phase I trial of a recombinant vaccinia virus that expresses carcinoembryonic antigen in patients with advanced colorectal cancer [J].

McAneny, D ;

Ryan, CA ;

Beazley, RM ;

Kaufman, HL .

ANNALS OF SURGICAL ONCOLOGY, 1996, 3 (05) :495-500

[9] On combining antineoplastic drugs with tumor vaccines [J].

Terando, A ;

Mulé, JJ .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2003, 52 (11) :680-685

[10] Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor [J].

Ullenhag, GJ ;

Frödin, JE ;

Jeddi-Tehrani, M ;

Strigård, K ;

Eriksson, E ;

Samanci, A ;

Choudhury, A ;

Nilsson, B ;

Rossmann, ED ;

Mosolits, S ;

Mellstedt, H .

CLINICAL CANCER RESEARCH, 2004, 10 (10) :3273-3281